First four weeks (2.5mg dose) The starting dose is primarily about tolerability
SeekPeptides has compiled the most comprehensive resource available on this topic, pulling from Phase 2 trial data published in the New England Journal of Medicine, emerging case series on GLP-1 allodynia , and practical management protocols from researchers navigating this exact situation
Combination therapy approaches If tirzepatide alone is insufficient, combination therapy may be the next step
Thiocell Glutathione Lozenges Unique lozenge form provides 500mg glutathione with vitamins C, D, and E
doi:10.3803/EnM.2024.1942 Lilly Investor Relations, News Release: Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine, May 11, 2025